<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8600942" created="08/05/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8600942</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="Organic_compound_other">Surfactant</term> suppresses <term id="T1" lex="NF-kappa_B_activation" sem="Other"><term id="T2" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> in human <term id="T3" lex="monocytic_cell" sem="Cell_natural">monocytic cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Surfactant suppresses NF-kappa B <clueType>activation</clueType> in human monocytic cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>Surfactant <clueType>suppresses</clueType> NF-kappa B activation <clueLoc>in human monocytic cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In addition to biophysical properties, <term id="T4" lex="pulmonary_surfactant" sem="Organic_compound_other">pulmonary surfactant</term> has <term id="T5" lex="immunomodulatory_activity" sem="Other">immunomodulatory activity</term>.</sentence>
<sentence id="S3">We previously demonstrated that both synthetic (<term id="T6" lex="Exosurf" sem="Organic_compound_other">Exosurf</term>) and <term id="T7" lex="modified_natural_surfactant" sem="Organic_compound_other">modified natural surfactant</term> (<term id="T8" lex="Survanta" sem="Organic_compound_other">Survanta</term>) downregulated <term id="T9" lex="endotoxin-stimulated_inflammatory_c_ytokine_mRNA_level" sem="Other"><term id="A2" sem="Lipid">endotoxin</term>-stimulated <term id="A3" sem="Protein_molecule">inflammatory c ytokine</term> <term id="A4" sem="RNA_molecule">mRNA</term> levels</term> and <term id="T11" lex="protein_product" sem="Protein_family_or_group">protein products</term> (<term id="T12" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term> [TNF], <term id="T13" lex="interleukin-1-beta" sem="Protein_molecule">interleukin-1-beta</term> [<term id="T14" lex="IL-1" sem="Protein_molecule">IL-1</term>], <term id="T15" lex="interleukin-6" sem="Protein_molecule">interleukin-6</term> [<term id="T16" lex="IL-6" sem="Protein_molecule">IL-6</term>]) in <term id="T17" lex="human_alveolar_macrophage" sem="Cell_natural">human alveolar <term id="T18" lex="macrophage" sem="Cell_natural">macrophages</term></term>.</sentence>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="A4"/>
<cause idref="A2"/>
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
<comment>NER T10 DEL</comment></event>
<event KT="Analysis" Source="Other" id="E4">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T6"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E5">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T8"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="T11"/>
<cause idref="A2"/>
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="A2"/>
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T12">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T12">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="A2"/>
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T14">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T14">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<cause idref="A2"/>
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T16">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T16">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event KT="Analysis" Source="Other" id="E10">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T6"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E11">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T6"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T6"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E13">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T6"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E14">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T8"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E15">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T8"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E16">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T8"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event KT="Analysis" Source="Other" id="E17">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T8"/>
<clue>We <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<sentence id="S4">In this study, we report that both <term id="T19" lex="Exosurf" sem="Organic_compound_other">Exosurf</term> and <term id="T20" lex="Survanta" sem="Organic_compound_other">Survanta</term> suppress <term id="T21" lex="TNF_mRNA" sem="RNA_family_or_group"><term id="A5" sem="Protein_molecule">TNF</term> mRNA</term> and secretion (85 +/- 4% mean percent inhibition +/- SEM by <term id="T22" lex="Exosurf" sem="Organic_compound_other">Exosurf</term>; 71 +/- 6% by <term id="T23" lex="Survanta" sem="Organic_compound_other">Survanta</term>) by <term id="T24" lex="endotoxin-stimulated_THP-1" sem="Cell_cultured"><term id="A6" sem="Lipid">endotoxin</term>-stimulated <term id="A7" sem="Cell_cultured">THP-1</term></term>, a <term id="T25" lex="human_monocytic_cell_line" sem="Cell_cultured">human monocytic cell line</term>.</sentence>
<event KT="Other" id="E18">
<type class="Negative_regulation"/>
<theme idref="T21"/>
<cause idref="T19"/>
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line</clueLoc>.</clue>
</event>
<event KT="Other" id="E19">
<type class="Negative_regulation"/>
<theme idref="T21"/>
<cause idref="T20"/>
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line</clueLoc>.</clue>
</event>
<event KT="Other" id="E20">
<type class="Localization"/>
<theme idref="A5"/>
<clue>In this study, we report that both Exosurf and Survanta suppress TNF mRNA and <clueType>secretion</clueType> (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line.</clueLoc></clue>
</event>
<event KT="Analysis" id="E21">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T19"/>
<clue>In this study, we <clueKT>report</clueKT> that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-stimulated THP-1, a human monocytic cell line.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T20"/>
<clue>In this study, we <clueKT>report</clueKT> that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-stimulated THP-1, a human monocytic cell line.</clue>
</event>
<event KT="Other" id="E51">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="A6"/>
<clue>In this study, we report that both Exosurf and Survanta suppress TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-<clueType>stimulated</clueType> THP-1, a human monocytic cell line.</clue>
</event>
<sentence id="S5">Because <term id="A8" sem="Lipid">surfactant</term> downregulated <term id="T26" lex="inflammatory_cytokine_production" sem="Other"><term id="T27" lex="inflammatory_cytokine" sem="Protein_family_or_group">inflammatory cytokine</term> production</term> similarly in both <term id="T28" lex="normal_human_alveolar_macrophage" sem="Cell_natural">normal human alveolar <term id="T29" lex="macrophage" sem="Cell_natural">macrophages</term></term> and the <term id="T30" lex="THP-1_cell_line" sem="Cell_cultured">THP-1 cell line</term>, we used this <term id="T31" lex="cell_line" sem="Cell_cultured">cell line</term> to investigate whether <term id="A9" sem="Lipid">surfactant</term> affected <term id="T32" lex="transcriptional_mechanism" sem="Other">transcriptional mechanisms</term>.</sentence>
<event id="E23">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>Because surfactant downregulated inflammatory cytokine <clueType>production</clueType> similarly in both normal human alveolar macrophages and the THP-1 cell line, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event id="E300">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="A8"/>
<clue>Because surfactant <clueType>downregulated</clueType> inflammatory cytokine production similarly <clueLoc>in</clueLoc> both <clueLoc>normal human alveolar macrophages</clueLoc> and the THP-1 cell line, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event id="E301">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="A8"/>
<clue>Because surfactant <clueType>downregulated</clueType> inflammatory cytokine production similarly <clueLoc>in</clueLoc> both normal human alveolar macrophages and <clueLoc>the THP-1 cell line</clueLoc>, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event KT="Investigation" id="E25" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T32"/>
<cause idref="A9"/>
<clue>Because surfactant downregulated inflammatory cytokine production similarly in both normal human alveolar macrophages and the THP-1 cell line, we used this cell line <clueKT>to investigate</clueKT> whether surfactant <clueType>affected</clueType> transcriptional mechanisms.</clue>
</event>
<sentence id="S6">Specifically, we examined <term id="T33" lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation" sem="Other"><term id="T34" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term> (<term id="T35" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>) activation</term> because it is crucial in <term id="T36" lex="transcriptional_regulation" sem="Other">transcriptional regulation</term> of many <term id="T37" lex="inflammatory_cytokine_gene" sem="DNA_family_or_group"><term id="T38" lex="inflammatory_cytokine" sem="Protein_family_or_group">inflammatory cytokine</term> genes</term> including <term id="T39" lex="TNF" sem="DNA_domain_or_region">TNF</term>, <term id="T40" lex="IL-1" sem="DNA_domain_or_region">IL-1</term>, and <term id="T41" lex="IL-6" sem="DNA_domain_or_region">IL-6</term>.</sentence>
<event KT="Investigation" id="E26" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>Specifically, we <clueKT>examined</clueKT> nuclear factor-kappa B (NF-kappa B) <clueType>activation</clueType> because it is crucial in transcriptional regulation of many inflammatory cytokine genes including TNF, IL-1, and IL-6.</clue>
</event>
<event KT="Other" id="E27">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="T35"/>
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> many inflammatory cytokine genes including TNF, IL-1, and IL-6.</clue>
</event>
<event KT="Other" id="E28">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T35"/>
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<event KT="Other" id="E29">
<type class="Regulation"/>
<theme idref="T40"/>
<cause idref="T35"/>
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<event KT="Other" id="E30">
<type class="Regulation"/>
<theme idref="T41"/>
<cause idref="T35"/>
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<sentence id="S7"><term id="T42" lex="electrophoretic_mobility_shift_assays" sem="Other">Electrophoretic mobility shift assays</term> showed that both <term id="T43" lex="surfactant" sem="Organic_compound_other">surfactants</term> decreased activation of <term id="T44" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>.</sentence>
<event KT="Other" id="E31">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<clue>Electrophoretic mobility shift assays showed that both surfactants decreased <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T19"/>
<clue>Electrophoretic mobility shift assays <clueKT>showed</clueKT> that <corefCause>both surfactants</corefCause> <clueType>decreased</clueType> activation of NF-kappa B.</clue>
</event>
<event KT="Analysis" id="E33">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T20"/>
<clue>Electrophoretic mobility shift assays <clueKT>showed</clueKT> that <corefCause>both surfactants</corefCause> <clueType>decreased</clueType> activation of NF-kappa B.</clue>
</event>
<sentence id="S8">The presence of both <term id="T45" lex="p65" sem="Protein_molecule">p65</term> and <term id="T46" lex="p50" sem="Protein_molecule">p50</term> <term id="T47" lex="NF-kappa_B_component" sem="Protein_molecule"><term id="T48" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> components</term> in <term id="T49" lex="LPS" sem="Lipid">LPS</term>-activated <term id="T50" lex="THP-1_cell" sem="Cell_cultured">THP-1 cells</term> was confirmed by specific <term id="T51" lex="antibody_induction" sem="Other">antibody induction</term> of supershifts in <term id="T52" lex="mobility_assay" sem="Other">mobility assays</term>.</sentence>
<event KT="Other" id="E34">
<type class="Physiological_process"/>
<theme idref="T50"/>
<cause idref="T49"/>
<clue>The presence of both p65 and p50 NF-kappa B components in LPS-<clueType>activated</clueType> THP-1 cells was confirmed by specific antibody induction of supershifts in mobility assays.</clue>
</event>
<event KT="Analysis" id="E35">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>The <clueType>presence</clueType> <linkTheme>of</linkTheme> both p65 and p50 NF-kappa B components <clueLoc>in LPS-activated THP-1 cells</clueLoc> was <clueKT>confirmed</clueKT> <clueExperiment>by specific antibody induction of supershifts in mobility assays.</clueExperiment></clue>
</event>
<event KT="Analysis" id="E50">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>The <clueType>presence</clueType> <linkTheme>of</linkTheme> both p65 and p50 NF-kappa B components <clueLoc>in LPS-activated THP-1 cells</clueLoc> was <clueKT>confirmed</clueKT> <clueExperiment>by specific antibody induction of supershifts in mobility assays.</clueExperiment></clue>
</event>
<sentence id="S9">These results are the first to suggest that surfactant&apos;s suppressive effects on <term id="T53" lex="inflammatory_cytokine_production" sem="Other"><term id="T54" lex="inflammatory_cytokine" sem="Protein_family_or_group">inflammatory cytokine</term> production</term> may involve <term id="T55" lex="transcriptional_regulation" sem="Other">transcriptional regulation</term> through inhibition of <term id="T56" lex="NF-kappa_B_activation" sem="Other"><term id="T57" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E36">
<type class="Gene_expression"/>
<theme idref="T54"/>
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine <clueType>production</clueType> may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E37">
<type class="Negative_regulation"/>
<theme idref="E36"/>
<cause idref="T19"/>
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> <clueType>suppressive</clueType> effects <linkTheme>on</linkTheme> inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E38">
<type class="Negative_regulation"/>
<theme idref="E36"/>
<cause idref="T20"/>
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> <clueType>suppressive</clueType> effects <linkTheme>on</linkTheme> inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E39">
<type class="Positive_regulation"/>
<theme idref="T57"/>
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E40">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T19"/>
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> suppressive effects on inflammatory cytokine production may involve transcriptional regulation through <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E41">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T20"/>
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> suppressive effects on inflammatory cytokine production may involve transcriptional regulation through <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation.</clue>
</event>
<event CL="L1" KT="Analysis" id="E42" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="E40"/>
<clue>These results are the first to <clueKT>suggest</clueKT> that surfactant&apos;s suppressive effects on inflammatory cytokine production <clueCL>may</clueCL> involve <clueType>transcriptional regulation</clueType> <linkCause>through</linkCause> inhibition of NF-kappa B activation.</clue>
</event>
<event CL="L1" KT="Analysis" id="E43" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E38"/>
<cause idref="E41"/>
<clue>These results are the first to <clueKT>suggest</clueKT> that surfactant&apos;s suppressive effects on inflammatory cytokine production <clueCL>may</clueCL> involve <clueType>transcriptional regulation</clueType> <linkCause>through</linkCause> inhibition of NF-kappa B activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
